Emerging Threat of Antimicrobial Resistance in β-Hemolytic Streptococci
- PMID: 32477287
- PMCID: PMC7242567
- DOI: 10.3389/fmicb.2020.00797
Emerging Threat of Antimicrobial Resistance in β-Hemolytic Streptococci
Abstract
Highly variable resistance rates to erythromycin and clindamycin have been reported in the β-hemolytic streptococcal species Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus dysgalactiae, depending on geographic and temporal context. In the present study we aimed to examine the longitudinal trends of antimicrobial resistance in these three species in a northern European setting. Furthermore, we used whole genome sequencing to identify resistance determinants and the mobile genetic elements involved in their dissemination, as well as elucidate phylogenetic relationships. All cases of invasive β-hemolytic streptococcal diseases in Health Region Bergen, western Norway, in the period 2004 to 2018 were retrospectively identified, comprising 271, 358, and 280 cases of S. pyogenes, S. agalactiae, and S. dysgalactiae, respectively. Antimicrobial susceptibility testing revealed a gradual but significant increase in erythromycin and clindamycin resistance for S. agalactiae and S. dysgalactiae during the study period. Whole genome sequencing of the erythromycin and clindamycin resistant bacterial population revealed a substantial phylogenetic diversity in S. agalactiae and S. dysgalactiae. However, the mobile genetic elements harboring the resistance determinants showed remarkable intra- and interspecies similarities, suggesting a dissemination of antimicrobial resistance predominantly through conjugative transfer rather than clonal expansion of resistant strains in these two species. Conversely, antimicrobial resistance in S. pyogenes remained low, apart from a transient outbreak of a clindamycin and erythromycin resistant emm11/ST403-clone in 2010-2012. Increased epidemiological attentiveness is warranted to monitor the emerging threat of antimicrobial resistance in β-hemolytic streptococci, particularly in S. agalactiae and S. dysgalactiae.
Keywords: Streptococcus agalactiae; Streptococcus dysgalactiae; Streptococcus pyogenes; antimicrobial resistance; β-hemolytic streptococci.
Copyright © 2020 Oppegaard, Skrede, Mylvaganam and Kittang.
Figures
Similar articles
-
Antimicrobial Resistance among Beta-Hemolytic Streptococcus in Brazil: An Overview.Antibiotics (Basel). 2021 Aug 12;10(8):973. doi: 10.3390/antibiotics10080973. Antibiotics (Basel). 2021. PMID: 34439023 Free PMC article. Review.
-
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).Diagn Microbiol Infect Dis. 2006 Jun;55(2):119-27. doi: 10.1016/j.diagmicrobio.2005.12.006. Epub 2006 Mar 10. Diagn Microbiol Infect Dis. 2006. PMID: 16530373
-
Species Identification of β-Hemolytic Streptococci from Diseased Companion Animals and Their Antimicrobial Resistance Data in Japan (2017).Jpn J Infect Dis. 2019 Mar 25;72(2):94-98. doi: 10.7883/yoken.JJID.2018.231. Epub 2018 Oct 31. Jpn J Infect Dis. 2019. PMID: 30381681
-
Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.Chemotherapy. 1997 Jan-Feb;43(1):10-20. doi: 10.1159/000239529. Chemotherapy. 1997. PMID: 8996736
-
Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999-2021.Emerg Infect Dis. 2023 Feb;29(2):260-267. doi: 10.3201/eid2902.221218. Emerg Infect Dis. 2023. PMID: 36692331 Free PMC article. Review.
Cited by
-
Pathogenesis, epidemiology and control of Group A Streptococcus infection.Nat Rev Microbiol. 2023 Jul;21(7):431-447. doi: 10.1038/s41579-023-00865-7. Epub 2023 Mar 9. Nat Rev Microbiol. 2023. PMID: 36894668 Free PMC article. Review.
-
Clonal Expansion of Multidrug-Resistant Streptococcus dysgalactiae Subspecies equisimilis Causing Bacteremia, Japan, 2005-2021.Emerg Infect Dis. 2023 Mar;29(3):528-539. doi: 10.3201/eid2903.221060. Emerg Infect Dis. 2023. PMID: 36823027 Free PMC article.
-
Interspecies recombination, not de novo mutation, maintains virulence after β-lactam resistance acquisition in Streptococcus pneumoniae.Cell Rep. 2022 Dec 13;41(11):111835. doi: 10.1016/j.celrep.2022.111835. Cell Rep. 2022. PMID: 36516783 Free PMC article.
-
Prevalence and predicting factors of Group A beta-hemolytic Streptococcus carrier state in primary schoolchildren.Ann Pediatr Cardiol. 2021 Oct-Dec;14(4):471-475. doi: 10.4103/apc.apc_280_20. Epub 2022 Mar 25. Ann Pediatr Cardiol. 2021. PMID: 35527766 Free PMC article.
-
Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017-2019.Emerg Infect Dis. 2022 Jan;28(1):118-126. doi: 10.3201/eid2801.210733. Emerg Infect Dis. 2022. PMID: 34932442 Free PMC article.
References
LinkOut - more resources
Full Text Sources
